Upcoming Exhibitions for 2024
Adtec looks forward to exhibiting at the Diabetic Foot Study Group (DFSG) conference between 6-8 September and the European Mechanical Support Summit (EUMS) conference between 11-14 September. At both conferences, we will have our SteriPlas Premium Cold Plasma medical device on our booth for a live demonstration. The SteriPlas boasts a strong clinical evidence collection of 80+ clinical trials and studies across a multitude of infection conditions.
To better understand our medical device and the positive imprint we have made on the severe infection conditions, please visit our booth during the two shows to see the SteriPlas in person.
Day 2 of the Malvern Diabetic Foot Conference
Day 2 of the Malvern Diabetic Foot Conference 2024. Don't forget to visit us to see how Premium Cold Plasma SteriPlas has healed chronic diabetic foot ulcers.
Day 2 of EWMA 2024
Day 2 of the European Wound Management Association (EWMA) exhibition. Visit us at booth G70 to see our Premium Cold Plasma live in action. With the strongest clinical efficacy for the infection management in wounds, surgical site infections and medical dermatology.
Day 1 of EWMA 2024
Day 1 of the European Wound Management Association (EWMA) exhibition. We have enjoyed catching up with friends and meeting new people interested in our Premium Cold Plasma medical device. Our Clinical Bibliography of 80+ clinical trials and studies puts us at the forefront of Cold Plasma Medicine for wounds, surgical site infections and medical dermatology. Visit us at booth G70 to learn more.
EWMA 2024
We look forward to exhibiting at the European Wound Management Association (EWMA) exhibition next week. Positioned at booth #G70, our Premium Cold Plasma medical device, the SteriPlas, will be featured to the public. Adtec Healthcare Cold Plasma company can boast of having very strong clinical trials data amongst a total of 80+ peer reviewed studies. Our medical device has proven anti-biofilm efficacy in chronic infections within wounds, surgical site infections and medical dermatology conditions.
Day 1 of the ISHLT
An exciting start to the ISHLT 2024 show. Our SteriPlas Premium Cold Plasma medical device is being widely spoken about throughout the sessions and we welcome you to visit our booth no.12 to learn more.
Adtec to exhibit at the ISHLT show
We are excited to be exhibiting at the ISHLT show next week. Our team will be onsite at booth no. 12 ready to welcome you and introduce you to our SteriPlas Premium Cold Plasma medical device used for the treatment of LVAD infections complicated with biofilm. Many of our customers will also be at the show who would be happy to give you a demonstration of our SteriPlas or to explain the strong clinical efficacy observed when using our medical device.
If you would like to secure a meeting in advance, please contact us at info@adtecplasma.com
Adtec joins the Innovation Platform at LSI 2024
We look forward to participating at the Innovation Platform at the @LSI USA 2024. Our CEO, Mary McGovern, will be in the Private Partnering Area between 18-22 March 2024 meeting with exclusive Medtech and Healthtech leaders to bring the rich content of the SteriPlas Premium Cold Plasma to them.
The SteriPlas is renowned for its proven clinical efficacy destroying chronic and complicated biofilm within infected wounds and surgical site infections. Our wide clinical bibliography of 80+ clinical trials and studies ranges from diabetic foot ulcers, LVAD infections, Sternal wound infections and so on.
Delivering a unique physical mode of action during treatment, the SteriPlas dense Cold Plasma ensures the total destruction of all bacterial species protected within biofilm which would otherwise have been resistant to antibiotics. Essentially, we are saving limbs !
We have documented the cost savings benefit due to be published this year across two separate papers focused on diabetic foot ulcers and sternal wound infections.
Our purpose of the LSI Innovation Platform attendance is to seek the potential of investment to help bring our medical device to new territories that have yet to benefit from what we can offer.
Cold Plasma is changing the norm of modern medicine.
Adtec visits Taiwan for SteriPlas expansion project
Who better to facilitate the expansion of the SteriPlas Premium Cold Plasma in the SE Asia market but the leading medical distributor, SG Biomedical. Adtec Healthcare Limited joins SG Biomedical in Taiwan to complete the introduction of three SteriPlas medical devices in the leading wound care hospitals.
Over 30 patients have so far been treated ranging from Diabetic Foot Ulcers, LVAD infections, Burn wounds, Vascular and Orthopaedic wounds and so on. All patients have had chronic infection with biofilm prior to being introduced to the SteriPlas. Some wounds have been non-healing for 4 years!
We are happy to report that over continued twice weekly use over the last two months, all patients are responding very well with most having been fully healed and no relapse of infection.
If you are within the Taiwan region and you are interested to learn more, please contact us so that we may introduce you to our partner.
Adtec's World Map
Launching an innovative and unknown technology on the medical market has only been successful due to the many years of clinical evidence and trust that we have accrued. From being the first company worldwide to introduce Cold Plasma on wounds in clinical trials to now being the leading manufacturer behind the most effective Cold Plasma medical device, Adtec Healthcare Limited has the strongest experience on how to successfully combat infections stalled by biofilm.
Our global presence of the SteriPlas Premium Cold Plasma is increasing with multiple clinics and distributors endorsing our medical device for chronic infection management of wounds, surgical site infections and medical dermatology.
There are multiple clinics in each country that help to spread the word of the benefit that our medical device brings to non-healing infections. Unfortunately, there is not enough space on this small map to reflect this!
We have also significantly increased our Distributor portfolio into new countries who are rapidly bringing the SteriPlas to their clinics and customers, with plans to expand even further into new territories which we are currently working on.
To learn more about the successes of our dense and rich Cold Plasma, send us a message at info@adtecplasma.com. We are also keen to reach out to new distributors who also wish to bring our Cold Plasma to their territories.